Corcept Therapeutics | CORT - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Assertio Holdings USD 39.91M 2.7M 2024-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
J&J USD 17.61B 235M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Merck USD 12.12B 596M 2025-09
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
Pacira USD 124.07M 8.8M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09